Managing Heart Failure Hospitalizations
MedPage Today,
Medical Journeys > Heart Failure Strategies for decongestion, inotropic support, and optimizing guideline-directed medical…
Medical Journeys > Heart Failure Strategies for decongestion, inotropic support, and optimizing guideline-directed medical…
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline…
Pearl 1: Quadruple-therapy in CKD What additional considerations are warranted when using these medications for patients with…
Madeline Sterling, MD, knew something was wrong when she heard her patient’s voice on the phone.
Madeline Sterling, MD, knew something was wrong when she heard her patient's voice on the phone.
Mortality and readmission rates were high, as were healthcare costs in EVOLUTION-HF, and few patients were taking GDMT.
Renin-angiotensin-aldosterone inhibitors (RAASi) are fundamental to the treatment of heart failure with reduced ejection…
HF specialists often do exactly the opposite of what they should be doing for those most at risk, editorialists say.
There are growing calls to initiate the “foundational” HFrEF drugs as soon as possible, but strategies have never been tested.
A healthcare provider logs into Biofourmis’ platform. The company received a breakthrough device designation for its software…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a…
Source: Biofourmis BiovitalsHF ® Approved for Expedited FDA Review Process as a First-in-Class DTx for Heart Failure that…
Digital therapy and virtual care startup Biofourmis received a breakthrough device designation from the Food and Drug…
Getting patients on max doses of guideline-directed heart failure therapies is important but also challenging, experts agree.
Meeting Coverage > TVT Current GDMT titration approach under fire during TVT debate Clinicians agreed on the need for an…
US costs for the drug are higher than in other countries, where studies have shown better cost-effectiveness ratios.
Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care…
Through ACC’s TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care The…
Through ACC's TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care…
Through ACC's TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care…
Through ACC's TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care…
WASHINGTON, April 28, 2021 /PRNewswire/ -- The American College of Cardiology (ACC) and HealthReveal, a leading clinical…
The American College of Cardiology (ACC) and HealthReveal, a leading clinical artificial intelligence company, are…
Through ACC's TRANSFORM program, three first-of-a-kind studies will apply implementation science to revolutionize care…
The American College of Cardiology (ACC) is planning a trio of studies that will measure whether personalized clinical…
Cardiology > CHF Disconnect reported between NYHA, KCCQ scores Patient-reported health status appeared to be more important…
This transcript has been edited for clarity. In the EPIC-HF trial, a patient activation tool comprising a short video and drug…
Heart failure affects an estimated 6.5 million adults in the United States, approximately 50% of whom have heart failure with…
Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder’s four foundational drug…
Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder’s four foundational drug…
Start most patients newly diagnosed with heart failure with reduced ejection fraction on the disorder's four foundational drug…
1. Receiving medications from a greater number of drug classes is linked to lower incidence of rehospitalization and death, for…
With over 50% of Americans developing 2 or more chronic conditions by the year 2030, it is now more critical than ever for…
Meeting Coverage > ACC VICTORIA trial dubbed a "win" for novel agent by Senior Editor, MedPage Today March 28, 2020 Novel oral…
Physicians on the front lines of healthcare delivery welcome the assistance of clinical decision support technology – as long…
Called Diabetes Can Break Your Heart, the initiative seeks to get doctors and patients talking about the connection between…
In the United States, there are more than 3 million patients living with hyperkalemia, yet this recurrent condition is often…
SOURCE Biofourmis Biofourmis joins American Heart Association's Center for Health Technology
SOURCE Biofourmis Biofourmis joins American Heart Association's Center for Health Technology
SOURCE Biofourmis Biofourmis joins American Heart Association's Center for Health Technology
SOURCE Biofourmis Biofourmis joins American Heart Association's Center for Health Technology
Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies to empower…
/PRNewswire/ -- Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies…
/PRNewswire/ -- Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies…
/PRNewswire/ -- Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and therapies…
Biofourmis joins American Heart Association's Center for Health Technology
BOSTON, /PRNewswire/ -- Biofourmis, a fast-growing digital therapeutics company focused on augmenting personalized care and…
SNOWMASS, COLO. – Many of the abundant missed opportunities to optimize pharmacotherapy for heart failure with reduced ejection…
SNOWMASS, COLO. – Many of the abundant missed opportunities to optimize pharmacotherapy for heart failure with reduced ejection…
Startups The company was founded last year and has developed technology that analyzes data from a combination of clinical and…
The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established guidelines and…
The consistent provision of guideline-directed medical therapy (GDMT) — care delivered according to established guidelines and…
Heart failure results when the heart is overburdened, for a variety of reasons, and blood flow stagnates causing a mixture of…
New UCLA-led study results revealed that between 27 percent and 67 percent of heart failure patients were not prescribed the…
A UCLA-led study found that many people with heart failure do not receive the medications recommended for them under guidelines…
Return to Article List UCLA RESEARCH ALERT Article ID: 698440 Released: 1-Aug-2018 4:05 PM EDT Source Newsroom: University of…
A UCLA-led study found that many people with heart failure do not receive the medications recommended for them under guidelines…
FINDINGS A UCLA-led study found that many people with heart failure do not receive the medications recommended for them under…
FINDINGS A UCLA-led study found that many people with heart failure do not receive the medications recommended for them under…